Concepedia

Hisham Mehanna

HM

Statistics

Publications

118

Citations

8.2K

H-Index

41

Active since

2001

Affiliations

University of Birmingham(Current)

University of Warwick

University Hospitals Coventry and Warwickshire NHS Trust

University of Liverpool

Newcastle University

Hisham Mehanna is an author at University of Birmingham specializing in medicine, oncology, and squamous cell carcinoma.

ORCID

Publications per year

2001–2025

118

Publications

118

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

Hisham Mehanna, Max Robinson, A. Hartley et al. · The Lancet · 2018 · 1K citations · Full text

, , +12

HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients

Xavier Castellsagué, Laia Alemany, Miquel Quer et al. · JNCI Journal of the National Cancer Institute · 2016 · 752 citations · Full text

, , +17

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

Ezra E.W. Cohen, R. Bryan Bell, Carlo Bifulco et al. · Journal for ImmunoTherapy of Cancer · 2019 · 738 citations · Full text

, , +13

PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer

Hisham Mehanna, Wai‐Lup Wong, Christopher C. McConkey et al. · New England Journal of Medicine · 2016 · 634 citations · Full text

, , +12

Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1–Low/Negative Recurrent or Metastatic HNSCC

Lillian L. Siu, Caroline Even, Éva Remenár et al. · JAMA Oncology · 2018 · 310 citations · Full text

, , +17

1–5 of 118